Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Grand River Appoints Mfg. Director | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Grand River Appoints Mfg. Director

Mr. Nole brings more than 15 years of sterile filling experience

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Steve Nole has been appointed director of Manufacturing at Grand River Aseptic Manufacturing (GRAM), and joins the executive management team. Mr. Nole will continue the company’s manufacturing campaigns, implementing high quality, budget friendly processes.
 
Mr. Nole has more than 15 years of sterile filling experience. Most recently, he was a senior manager in Global Biologics for Pfizer, where he managed the fill/finish operations and helped with commissioning activities for a new fill/finish facility in Andover, MA. In his 12 years at Pfier, he served in a number of roles of increasing responsibility at three different Pfizer locations. He began his career at King Pharmaceuticals (now Par/JHP Pharmaceuticals), where he became the supervisor of Sterile Filling and a scientist for Pharmaceutical Technology.
 
GRAM president Tom Ross said, “We are thrilled to welcome Steve to the GRAM team. This is an exciting time for GRAM and Steve’s experience and knowledge will be instrumental to delivering high quality products and services to each of our customers.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics